Replies to post #5340 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Long Term

Hope you're right about the long-term...this is over a year old, but they appear to share your opinion.

By 2017, the buprenorphine implant will emerge as the gold-standard therapy in our Drug Comparator Model because of its superior clinical profile over the key current therapies we evaluated.

http://decisionresources.com/Products-and-Services/Report?r=dbascg0114